Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02808780 · ClinicalTrials.gov registry record

An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis

A clinical trial of Ulcerative Colitis, sponsored by Janssen Biotech.

Active
Registry status
537
Enrollment target
20
Study locations

NCT02808780 is a study of Ulcerative Colitis that is active but no longer recruiting, run by Janssen Biotech. The registered enrollment target is 537 participants, below the 2,053-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (74% lower). The trial reports 20 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02808780, a study of Ulcerative Colitis, is active but no longer recruiting, sponsored by Janssen Biotech.

ACTIVE NOT RECRUITING
Registry status
537 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to describe the long-term safety risks in adult participants with moderate-to-severe ulcerative colitis who are treated with Simponi.

Conditions Studied

Ulcerative Colitis

Study Locations (20)

Florida

  • - Coral Gables
  • - Fort Myers
  • - Lake Worth
  • - Lauderdale Lakes
  • - Miami
  • - Tampa

California

  • - Murrieta
  • - Rialto
  • - Ventura

Other

  • - Salzburg
  • - Sankt Poelten Noe
  • - Vienna

Texas

  • - Houston
  • - San Antonio

Georgia

  • - Suwanee

Illinois

  • - Chicago

Ohio

  • - Sylvania

Pennsylvania

  • - Pittsburgh

Trial Details

FieldValue
Enrollment Target 537 participants
Start Date 2016-12-16
Est. Completion 2027-03-11

Sponsor

Janssen Biotech

8 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02808780

The ClinicalTrials.gov registry entry for NCT02808780 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 537 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,053-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (74% lower). The listed sponsor is Janssen Biotech, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ulcerative Colitis appearing as the primary indexed condition, and to 0 interventions.

NCT02808780 reports 20 study locations spanning 10 distinct geographic areas - top geographies include Florida, California, Other.

Frequently Asked Questions

What is clinical trial NCT02808780 about?

NCT02808780 is a clinical study titled "An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis". The purpose of this study is to describe the long-term safety risks in adult participants with moderate-to-severe ulcerative colitis who are treated with Simponi.

What is the current status of trial NCT02808780?

This trial is currently active not recruiting. The enrollment target is 537 participants. The study started on 2016-12-16. Estimated completion is 2027-03-11.

What conditions does trial NCT02808780 study?

This clinical trial studies the following conditions: Ulcerative Colitis.

Who is sponsoring clinical trial NCT02808780?

This trial is sponsored by Janssen Biotech, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02808780 being conducted?

This trial has 20 study locations across California, Florida, Georgia, Illinois, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Ulcerative Colitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Ulcerative Colitis

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.